ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: AACR To Have Fur Symposia, Including One With ASCO; McConnell Names TRTP Director

March 21, 1986

NCI Planning Phase III Study Of Avastin For Metastatic Colorectal Cancer

June 27, 2003

Cooperative Group-cancer control Program To Continue

August 10, 1979

Conversation with The Cancer Letter: Einhorn: “I Still Harbor Hope For Similar Success Stories”

October 24, 2014

Pittsburgh Cancer Institute Gets NCI Core Grants

June 24, 1988

ACS Funds Pilot Study Of Mammography Trial

July 28, 1995